Navigation Links
ARAMARK Agrees to Sell its Galls Business to CI Capital Partners
Date:10/3/2011

PHILADELPHIA, Oct. 3, 2011 /PRNewswire/ -- ARAMARK, a global provider of professional services, announced today it has sold Galls, a leading provider of public safety equipment and apparel, to CI Capital Partners, a North American private investment firm. The terms of the transaction were not disclosed.  

(Logo: http://photos.prnewswire.com/prnh/20110907/PH63208LOGO)

Based in Lexington, Kentucky, Galls sells a wide variety of public safety products to leading law enforcement, fire and EMS agencies, private security companies and federal agencies so they can perform at their best.  

"Galls has earned its excellent reputation of providing public safety and emergency medical personnel with quality equipment and apparel and outstanding service," said Joseph Neubauer, Chairman and CEO of ARAMARK. "It has succeeded by continually anticipating the needs of customers and clients and by being dedicated to their success. This opportunity with CI Capital Partners enables Galls to pursue accelerated expansion and better positioning on which to grow and build its brand."

"We are very thrilled to complete a transaction that will provide Galls with the ability to continue its internal growth as well as pursue attractive acquisition opportunities. CI Capital has a long track record of growing distribution businesses and we are excited to build significant value at Galls," said Larry Dismukes, President of Galls.

About ARAMARK

ARAMARK is a leader in professional services, providing award-winning food servicesfacilities management, and uniform and career apparel to health care institutionsuniversities and school districtsstadiums and arenas, and businesses around the world. The company is recognized as one of the "World's Most Ethical Companies" by the Ethisphere Institute, as the industry leader in FORTUNE magazine's "World's Most Admired Companies," and as one of America's Largest Private Companies by both FORTUNE and Forbes magazines. ARAMARK seeks to responsibly address issues that matter to its clients, customers, employees and communities by focusing on employee advocacy, environmental stewardship, health and wellness, and community involvement. Headquartered in Philadelphia, ARAMARK has approximately 255,000 employees serving clients in 22 countries. Learn more at www.twitter.com/aramarknews.

About CI Capital Partners

CI Capital Partners is a North American private investment firm focused on building and expanding leading middle market businesses. The firm targets industries that are ripe for consolidation and seeks to substantially scale businesses through organic growth and acquisitions. Since its founding in 1993, the firm and its portfolio companies have made over 95 acquisitions repenting over $5 billion in enterprise value. CA Capital's existing portfolio consists of companies which collectively generate annual revenue of approximately $4.0 billion, EBITDA of $350 million and have more than 14,000 employees. To learn more, please visit www.cicapllc.com

Contact Information:

Sarah Jarvis, ARAMARK Communications
T: 215-238-7168
Jarvis-sarah@aramark.com


'/>"/>
SOURCE ARAMARK
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics
2. Valeant Pharmaceuticals Agrees to Acquire Dermik
3. BioMarin Agrees to Acquire Biologics Manufacturing Plant in Ireland from Pfizer
4. Devicor™ Medical Products, Inc. Agrees to Acquire Neoprobes Gamma Detection Devices
5. Biofield Corporations 51% Owned Subsidiary Agrees to Deal Appointing McKinley Infocapital as Korean Exclusive Distributor of Breast Cancer Diagnostic System; Contract has Potential Value of up to $15.3 Million
6. Quest Diagnostics Agrees to Repurchase 15.4 Million Shares From Largest Shareholder
7. Xanodyne Agrees to Withdraw Propoxyphene From the U.S. Market
8. Boston Scientific Agrees to Sell Neurovascular Business to Stryker
9. Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia
10. Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex® Overactive Bladder Treatment for $400 Million in Cash
11. Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... -- The global pacemaker market is expected to reach ... report by Grand View Research, Inc. The heightening prevalence ... coverage is a key driving factor governing the growth ... devices are supporting the expansion of this vertical. ... growth rendering driver for this market. A death estimate ...
(Date:1/16/2017)... , Jan. 16, 2017 Derek H. ... Law Firm, was recently appointed Liaison Counsel in ... for all Xarelto cases. In this role, Potts was ... and will actively assist the Court and Co Lead ... Milstein Adelman Jackson Fairchild & Wade ...
(Date:1/16/2017)...  Harrington Discovery Institute at University Hospitals in ... of The Harrington Project for Discovery & Development ... in collaboration with Alzheimer,s Drug Discovery Foundation (ADDF), ... Harrington Discovery Institute collaborations are ... into new medicines that will improve human health, ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... January 16, 2017 , ... St. Louisans are well-aware of the following facts at present:, ... influenza shot seems to be having no effect on keeping this particularly bad strain of ... people around are coughing, sneezing, or sniffling , These facts are well-known ...
(Date:1/16/2017)... ... January 16, 2017 , ... Board-certified oculoplastic surgeon Dr. Mehryar ... official journal of The American Society for Aesthetic Plastic Surgery, in which he ... designed to correct drooping, retracted lower eyelids, which usually result from genetics, injury, ...
(Date:1/16/2017)... ... , ... One thing common to all types of cancer is that it’s ... The money spent screening for and treating cancer in the United States is estimated ... more than in any other country that has an advanced healthcare system, sometimes spending ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... been appointed Chief Executive Officer of the medical device company, effective immediately. , ... Robert Storey. “Kevin has a strong track record in medical device market ...
(Date:1/15/2017)... New York, NY (PRWEB) , ... January 15, 2017 , ... ... growing strategic accounts in the United States for the asthma & allergy friendly mark. ... of America to independently test and identify consumer products to be more suitable for ...
Breaking Medicine News(10 mins):